Higher red blood cell distribution width predicts thrombosis risk in primary and secondary myelofibrosis
Ann Hematol
.
2022 Jun;101(6):1355-1357.
doi: 10.1007/s00277-021-04724-4.
Epub 2021 Nov 26.
Authors
Marko Lucijanic
1
2
,
Ivan Krecak
3
,
Srdan Verstovsek
4
,
Ena Soric
5
,
Davor Galusic
6
7
,
Hrvoje Holik
8
9
,
Vlatka Perisa
9
10
,
Martina Moric Peric
11
,
Ivan Zekanovic
11
,
Rajko Kusec
5
12
Affiliations
1
Hematology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia. markolucijanic@yahoo.com.
2
University of Zagreb School of Medicine, Ul. Salata 3, 10000, Zagreb, Croatia. markolucijanic@yahoo.com.
3
Department of Internal Medicine, General Hospital Sibenik, Ul. Stjepana Radica 83, 22000, Sibenik, Croatia.
4
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
5
Hematology Department, University Hospital Dubrava, Av. Gojka Suska 6, 10000, Zagreb, Croatia.
6
Department of Hematology, University Hospital of Split, Soltanska ul. 1, 21000, Split, Croatia.
7
School of Medicine, University of Split, Soltanska ul. 2, 21000, Split, Croatia.
8
Department of Internal Medicine, Josip Bencevic" General Hospital, Ul. Andrije Štampara, "Dr, 35000, Slavonski Brod, Croatia.
9
Faculty of Medicine, University of Osijek, Ul. Josipa Huttlera 4, 31000, Osijek, Croatia.
10
Department of Hematology, Osijek University Hospital, Ul. Josipa Huttlera 4, 31000, Osijek, Croatia.
11
Department of Internal Medicine, General Hospital Zadar, Ul. Boze Pericica 5, 23000, Zadar, Croatia.
12
University of Zagreb School of Medicine, Ul. Salata 3, 10000, Zagreb, Croatia.
PMID:
34825960
DOI:
10.1007/s00277-021-04724-4
No abstract available
Publication types
Letter
MeSH terms
Erythrocyte Indices
Erythrocytes
Humans
Primary Myelofibrosis* / complications
Risk Factors
Thrombosis* / etiology